Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma

NCT07831369 is registered in ClinicalTrials.gov with Inova Health Care Services as lead sponsor.

NCT NCT07831369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07831369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
Lead sponsor
Inova Health Care Services
Phase
Phase 2
Overall status
Recruiting
Start date
September 4, 2026
Completion date
December 30, 2030
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

astrocytoma, idh-mutant, grade 4, glioblastoma